Alibaba Pays $600M Over Drug Sales Probe

NewsAlibaba Pays $600M Over Drug Sales Probe

Settlement resolves US illegal drug sales probe

Alibaba will pay $600 million to settle US illegal drug sales allegations after federal authorities said the company failed for years to stop banned pharmaceuticals, chemicals and pill-making equipment from moving through its online marketplaces. Its United States-based payment processor, AUS Merchant Services, is also part of the resolution.

The US Department of Justice said on Wednesday that both companies entered into non-prosecution agreements, meaning prosecutors will not bring criminal charges if the companies meet the terms of the deal. As part of the settlement, Alibaba and AUS Merchant Services accepted responsibility for the actions of their officers and employees and agreed to strengthen compliance programmes. In plain terms: the referees found the system had holes, and the fix is now part of the scorecard.

What the Justice Department says happened

According to the Justice Department, Alibaba admitted that from 2016 to 2024 it failed to prevent about 80,000 sales of prohibited products that were imported into the US from overseas.

Federal officials said the products included:

  • Illegal drugs
  • Chemicals used in drug manufacturing
  • Pharmaceutical counterfeiting equipment
  • Pill presses

Those transactions had a combined merchandise value of more than $200 million, according to the department.

Most read

  1. CelebrityDolly Parton’s Cause of Death Confirmed
  2. EntertainmentRupert Grint Has No Idea How Rich He Really Is
  3. CelebrityMeghan Markle Household Staff Claims Resurface

The allegations centred on violations of the US Federal Food, Drug, and Cosmetic Act. Prosecutors said merchants used Alibaba’s e-commerce platforms to sell and import products that were illegal, unapproved, misbranded or dangerous.

Alibaba operates major global marketplaces including Alibaba.com and AliExpress.com, giving the case a familiar modern problem: enormous platforms, millions of listings and compliance systems asked to keep pace with all of it. Not exactly a low-traffic corner shop.

Undercover purchases and internal concerns

US law enforcement officers from multiple government agencies carried out more than 40 undercover purchases during the investigation, according to the Justice Department. Those purchases included pharmaceuticals and equipment that were illegal to import into the US.

The department also said Alibaba employees at times raised concerns internally about whether illegal products were being sold and whether the company’s compliance measures were inadequate to stop those sales.

That detail matters because the case was not framed only as a bad-merchant problem. Prosecutors described gaps in the company’s controls, policies and enforcement, not merely a few sellers slipping through a digital net the size of a continent.

Payment processor also faulted

AUS Merchant Services, Alibaba’s US-based payment processor, was also included in the settlement. The US government said its anti-money laundering compliance programme failed to prevent some merchants from using its services to facilitate the sale and importation of banned products.

Anti-money laundering rules are meant to stop payment systems from being used to support illegal trade or disguise unlawful proceeds. In this case, authorities said the processor’s controls did not adequately block transactions tied to prohibited goods.

The settlement requires both companies to improve compliance programmes, though the Justice Department did not frame the agreement as the end of scrutiny for the sector. If anything, it reads like a reminder to large digital marketplaces that scale is not a defence strategy.

Alibaba says it cooperated

Alibaba said in a statement that the settlement followed a thorough regulatory process and reflected its cooperation with US authorities.

“This settlement reflects a thorough regulatory process with Alibaba’s full cooperation and our commitment to best-in-class standards of control, policies, and measures against non-compliant product sales,” the company said.

Assistant US Attorney General Brett Shumate said the resolution showed the Justice Department’s focus on online marketplaces and payment platforms.

“Today’s resolution reflects the Department of Justice’s commitment to ensuring that companies operating e-commerce and digital payment platforms keep illegal, unapproved, misbranded, and dangerous foreign pharmaceuticals off their marketplaces,” Shumate said.

The broader message is straightforward enough: when a marketplace becomes global infrastructure, regulators expect the back-end controls to act like infrastructure too, not like optional decoration.

Tags:
alibaba illegal drug salesus justice departmente-commerce complianceaus merchant services

About The Hook Editorial Team

Editorial Team

The Hook Editorial Team delivers daily news reporting and analysis.